Biotechnologie

The Biotechnology theme focuses on harnessing living systems, genetic engineering, and molecular tools to develop novel therapeutics, diagnostics, and biomanufacturing processes. Core tracks include gene and cell therapy, biologics and biosimilars, genome editing/CRISPR, synthetic biology and bioprocessing, next‑generation sequencing and precision diagnostics, microbiome platforms, and AI‑enabled drug discovery.The sector's total market cap is 918.48 billion HKD, with a 24h change of -0.20%. Among 14 constituents, 6 are up (42.86%) and 8 are down (57.14%). The top gainer is GENSCRIPT BIO (01548), with a 24h increase of +4.47%.Leader-led resilience amid mild consolidation suggests pause, not reversal. Trade momentum around upcoming catalysts; accumulate cash‑rich innovators on dips, prioritizing proven pipelines and risk control over speculative names.